Ziwig Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 100

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 7

Ziwig General Information

Description

Developer of non-invasive diagnostic tests designed for women's health. The company's technology features salivary RNA analysis, next-generation sequencing, artificial intelligence modeling, molecular biology, transcriptomic profiling, and high-throughput laboratory analysis, enabling healthcare professionals to obtain reliable endometriosis diagnoses and reduce patient diagnostic delays.

Contact Information

Website
www.ziwig.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 19 Rue Riboud
  • 69003 Lyon
  • France
+33 04
Primary Industry
Laboratory Services (Healthcare)
Vertical(s)
Life Sciences
Corporate Office
  • 19 Rue Riboud
  • 69003 Lyon
  • France
+33 04

Ziwig Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ziwig Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ziwig‘s full profile, request access.

Request a free trial

Ziwig Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 4

    Pending

  • Expiring in next 12 mo

Ziwig Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026046804-A1 Normalisation prior to sequencing Pending 29-Aug-2024
FR-3165893-A1 Normalization before sequencing Active 29-Aug-2024
FR-3165893-B1 Normalization before sequencing Active 29-Aug-2024
EP-4634922-A1 Method for identifying extracellular rna biomarkers in body fluid samples in view of detecting cancers and other pathologies such as endometriosis Pending 12-Dec-2022
US-20260204346-A1 Method for identifying extracellular rna biomarkers in body fluid samples in view of detecting cancers and other pathologies such as endometriosis Pending 12-Dec-2022 G16B20/20
To view Ziwig’s complete patent history, request access »

Ziwig Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ziwig Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ziwig‘s full profile, request access.

Request a free trial

Ziwig FAQs

  • When was Ziwig founded?

    Ziwig was founded in 2014.

  • Where is Ziwig headquartered?

    Ziwig is headquartered in Lyon, France.

  • What is the size of Ziwig?

    Ziwig has 100 total employees.

  • What industry is Ziwig in?

    Ziwig’s primary industry is Laboratory Services (Healthcare).

  • Is Ziwig a private or public company?

    Ziwig is a Private company.

  • What is the current valuation of Ziwig?

    The current valuation of Ziwig is .

  • What is Ziwig’s current revenue?

    The current revenue for Ziwig is .

  • How much funding has Ziwig raised over time?

    Ziwig has raised $56.6M.

  • Who are Ziwig’s investors?

    Albo Club, Financière IDAT, Mindstone Fund, Super Capital, and TenNine VC are 5 of 11 investors who have invested in Ziwig.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process